Insulin Giants Beat RICO Claims Brought By Patients
A proposed class of diabetes patients who say three major insulin manufacturers caused them to overpay for the medication can't pursue Racketeer Influenced and Corrupt Organizations Act claims against the drugmakers,...To view the full article, register now.
Already a subscriber? Click here to view full article